Indigenous pharma-ceutical company, May & Baker Nigeria Plc, said it recorded 10 per cent growth in 2015 despite the economic crisis at the time.
The Managing Director, M&B, Mr. NnamdiOkafor, at a customers’ forum in Lagos on Thursday, said the growth exceeded the pharmaceutical industry’s growth of 13 per cent.
He said, “The review period, 2015, was a difficult year for business, particularly for our industry for reasons we are all familiar with ranging from the general elections to security issues in the North-East to macro-economic issues in the last quarter.
“But I am delighted to announce to you that in spite of these adverse conditions in 2015, our company recorded her best performance in four years.”
Okafor said that with forex putting pressure on manufacturing, the company planned to innovate and keep reviewing its business processes aimed at making it more productive in 2016.
According to him, new products will also be introduced to give consumers more varieties and shareholders’ profit opportunities.
The Head, Pharmaceutical Sales and Marketing, Mr. ChukwutemChukwuka, said the company aimed for a 19 per cent business growth in 2016 through increasing support for brands by making information more available.
